These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8023159)

  • 1. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1994 Jul; 265(5170):386-91. PubMed ID: 8023159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.
    McCoy M; Stavridi ES; Waterman JL; Wieczorek AM; Opella SJ; Halazonetis TD
    EMBO J; 1997 Oct; 16(20):6230-6. PubMed ID: 9321402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the tetrameric minimum transforming domain of p53.
    Lee W; Harvey TS; Yin Y; Yau P; Litchfield D; Arrowsmith CH
    Nat Struct Biol; 1994 Dec; 1(12):877-90. PubMed ID: 7773777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone dynamics of the oligomerization domain of p53 determined from 15N NMR relaxation measurements.
    Clubb RT; Omichinski JG; Sakaguchi K; Appella E; Gronenborn AM; Clore GM
    Protein Sci; 1995 May; 4(5):855-62. PubMed ID: 7663341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined solution structure of the oligomerization domain of the tumour suppressor p53.
    Clore GM; Ernst J; Clubb R; Omichinski JG; Kennedy WM; Sakaguchi K; Appella E; Gronenborn AM
    Nat Struct Biol; 1995 Apr; 2(4):321-33. PubMed ID: 7796267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
    Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
    Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy.
    Drohat AC; Amburgey JC; Abildgaard F; Starich MR; Baldisseri D; Weber DJ
    Biochemistry; 1996 Sep; 35(36):11577-88. PubMed ID: 8794737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA.
    Klein C; Planker E; Diercks T; Kessler H; Künkele KP; Lang K; Hansen S; Schwaiger M
    J Biol Chem; 2001 Dec; 276(52):49020-7. PubMed ID: 11606582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
    Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the p53 core domain dimer bound to DNA.
    Ho WC; Fitzgerald MX; Marmorstein R
    J Biol Chem; 2006 Jul; 281(29):20494-502. PubMed ID: 16717092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin 4. The solution structure of a four-helix bundle protein.
    Smith LJ; Redfield C; Boyd J; Lawrence GM; Edwards RG; Smith RA; Dobson CM
    J Mol Biol; 1992 Apr; 224(4):899-904. PubMed ID: 1569578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solution structure of the Tyr41-->His mutant of the single-stranded DNA binding protein encoded by gene V of the filamentous bacteriophage M13.
    Folkers PJ; Nilges M; Folmer RH; Konings RN; Hilbers CW
    J Mol Biol; 1994 Feb; 236(1):229-46. PubMed ID: 8107108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.
    Mateu MG; Fersht AR
    EMBO J; 1998 May; 17(10):2748-58. PubMed ID: 9582268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR studies of the secondary structure in solution and the steroid binding site of delta5-3-ketosteroid isomerase in complexes with diamagnetic and paramagnetic steroids.
    Zhao Q; Abeygunawardana C; Mildvan AS
    Biochemistry; 1997 Mar; 36(12):3458-72. PubMed ID: 9131995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor.
    Johnson CR; Morin PE; Arrowsmith CH; Freire E
    Biochemistry; 1995 Apr; 34(16):5309-16. PubMed ID: 7727392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding topology of the disulfide-bonded dimeric DNA-binding domain of the myogenic determination factor MyoD.
    Starovasnik MA; Blackwell TK; Laue TM; Weintraub H; Klevit RE
    Biochemistry; 1992 Oct; 31(41):9891-903. PubMed ID: 1327135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.
    Rippin TM; Freund SM; Veprintsev DB; Fersht AR
    J Mol Biol; 2002 May; 319(2):351-8. PubMed ID: 12051912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.